J 2022

Thirteenth Annual ENBDC Workshop: Methods in Mammary Gland Biology and Breast Cancer

TWIGGER, Alecia-Jane, Jakub SUMBAL, Mohamed BENTIRES-ALJ and Beatrice A. HOWARD

Basic information

Original name

Thirteenth Annual ENBDC Workshop: Methods in Mammary Gland Biology and Breast Cancer

Authors

TWIGGER, Alecia-Jane, Jakub SUMBAL (203 Czech Republic, belonging to the institution), Mohamed BENTIRES-ALJ and Beatrice A. HOWARD (guarantor)

Edition

Journal of Mammary Gland Biology and Neoplasia, New York (NY, USA), SPRINGER/PLENUM PUBLISHERS, 2022, 1083-3021

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 2.500

RIV identification code

RIV/00216224:14110/22:00128413

Organization unit

Faculty of Medicine

UT WoS

000868366100001

Keywords in English

Mammary gland biology; Breast cancer; Breast development; Ductal carcinoma in situ; Organoids; Lobular breast cancer; Patient-derived xenografts; Resistance to endocrine therapy; In vivo live imaging; Lactation

Tags

Tags

International impact, Reviewed
Změněno: 31/1/2023 08:04, Mgr. Tereza Miškechová

Abstract

V originále

The thirteenth annual workshop of the European Network for Breast Development and Cancer (ENBDC) Laboratories Annual Workshop took place on the 28-30 April 2022 in Weggis, Switzerland and focused on methods in mammary gland biology and breast cancer. Sixty scientists participated in the ENBDC annual workshop which had not been held in person since 2019 due to the global COVID-19 pandemic. Topics spanned the mammary gland biology field, ranging from lactation biology and embryonic development, single cell sequencing of the human breast, and stunning cutting-edge imaging of the mouse mammary gland and human breast as well as breast cancer research topics including invasive progression of the pre-invasive DCIS stage, metabolic determinants of endocrine therapy resistance, models for lobular breast cancer, and how mutational landscapes of normal breast during age and pregnancy determine cancer risk. The latest findings from participating researchers were presented through oral presentations and poster sessions and included plenty of unpublished work.